Cairo, Egypt
Cairo, Egypt

Sinai University is a private university in Sinai, Egypt. It was established in 2006. Its president is Professor Hatem Mostafa El-Bolok and the chairman of its board of trustees is the Egyptian businessman Hassan Rateb. It comprises 7 faculties which are: Faculty of Dentistry Faculty of Business Administration Faculty of Engineering science Faculty of Information System and Computer Science Faculty of Media Technology Faculty of Pharmacy and Pharmaceutical Industries Faculty of Humanities↑ ↑ ↑ Wikipedia.

SEARCH FILTERS
Time filter
Source Type

PURPOSE:: To classify the appearance of the optic disc seen on fundus photographs of healthy subjects and patients with or suspected glaucoma whose diagnosis was based upon visual fields (VFs) and spectral-domain optical coherence tomography (sdOCT) results. PATIENTS AND METHODS:: One eye of 100 patients with or suspected glaucoma and 62 healthy subjects were prospectively tested with 24-2 and 10-2 VF and macular and disc sdOCT cube scans. All eyes with or suspected glaucoma had a 24-2 mean deviation better than −6.0 dB and an abnormal appearing disc on stereophotographs. The retinal ganglion cell plus inner plexiform layer (RGC+) from the macular scans and the retinal nerve fiber layer (RNFL) from the macular and disc scans were segmented and converted to probabilities plots. An eye was considered “glaucoma” if the sdOCT probability plots showed an abnormality in a region that corresponded to a defect seen on the 24-2 and/or 10-2 VF total deviation plot. Similarly, an eye was considered “suspect” only if both the sdOCT and VF plots were normal. Healthy subjects (normal VFs and sdOCT) were classified as “controls” and used as reference for comparisons. Glaucoma specialists reviewed the stereophotographs and classified eyes based on the presence of signs suggestive of glaucomatous optic neuropathy. RESULTS:: The pattern of clinical signs of glaucomatous optic neuropathy seen on stereophotographs was statistically different between glaucoma (P<0.001) and suspects (P<0.001) vs. controls and explained up to 68% of the total variance of the diagnosis based upon sdOCT and VFs. Vertical cup-to-disc>0.6, focal neuroretinal rim thinning, focal RNFL loss, and violation of the ISNT rule had the best performance to differentiate glaucoma and suspects from controls. Compared with the suspect group, glaucoma eyes (abnormal sdOCT and VF tests) were more likely to have vertical cup-to-disc>0.6 (92% vs. 69%, P=0.003), diffuse rim (53% vs. 9%, P<0.001) and RNFL (61% vs. 26%, P<0.001) thinning, and β-zone parapapillary atrophy (68% vs. 17%, P<0.001). CONCLUSIONS:: Focal and diffuse signs of glaucoma damage seen on stereophotographs often match damage shown on VFs and sdOCT. In addition, damage shown on VFs and sdOCT is often missed during clinical evaluation. Longitudinal studies ought to differentiate focal signs of glaucoma damage seen on stereophotography from false-positives or very early loss. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.


Casper R.F.,Sinai University
Fertility and Sterility | Year: 2017

In this views and reviews series of articles, we focus on the long-term medical management of endometriosis in lieu of surgery. The development of noninvasive biomarkers will facilitate the early diagnosis of endometriosis and early medical management. We discuss the use of oral progestin-only as first line treatment in place of oral contraceptives. Future medical treatments may be curative rather than simply suppressive or palliative. The section on surgery mainly pertains to failed medical management or specific types of endometriosis which require surgical excision. © 2017 American Society for Reproductive Medicine


Bogdanovic E.,Sinai University
Biochimica et Biophysica Acta - General Subjects | Year: 2015

Background Since the initial discovery of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in a large subset of human low-grade gliomas and acute myelogenous leukemia (AML), much interest focused on the function of IDH1 and on the relationship between mutations in IDH1 and tumor progression. To date, mutations in the IDH1 gene have been found in numerous cancers with the highest frequencies occurring in gliomas, chondrosarcomas/enchondromas and cholangiocarcinomas. Scope of review IDH1 was first described in the scientific literature as early as 1950. Early researchers proposed that the enzyme likely functions in cellular lipid metabolism based on the observation that the enzymatic reaction produces NADPH and partially localizes to peroxisomes. This article highlights the studies implicating IDH1 in cytoplasmic and peroxisomal lipid metabolism from the early researchers to the recent studies examining mutant IDH1R132, the most common IDH1 mutation found in cancer. Major conclusions While a role for IDH1 in lipid biosynthesis in the liver and adipose tissue is now established, a role in lipid metabolism in the brain and tumors is beginning to be examined. The recent discoveries that IDH1R132H interferes with the metabolism of phospholipids in gliomas and that IDH1 activity could participate in the synthesis of acetyl-CoA from glutamine in hypoxic tumors highlight roles for IDH1 in lipid metabolism in a broad spectrum of tissues. General significance Interferences in cytoplasmic and peroxisomal lipid metabolism by IDH1R132 may contribute to the more favorable clinical outcome in patients whose tumors express mutations in the IDH1 gene. © 2015 Elsevier B.V. All rights reserved.


Empirical evidences in the last three decades confirmed that designs that connect humans to natural contents and landscape configurations, help to enhance humans' overall sense of wellbeing, with positive and therapeutic consequences on physiology. Findings in the field of environmental psychology showed also that these features have positive effects on human productivity and can reduce stress. Opportunities for contact with these elements are, however, increasingly reduced in modern urban life. Therefore, more attention has been recently paid by architectural theorists to find ways to reconnect the built environment to these elements. Biophilia is one of the most recent and viable reconnection theories in this field. This paper highlights the underpinnings of this design theory and addresses the assumption that one of the reasons behind the great admiration that most of the people have for historical buildings attributes to the biophilic qualities found in these buildings. By drawing inspiration from historical architecture, and by use of a qualitative analytical methodology that typify certain characteristics in then, this paper brings in conclusion specific biophilic strategies and settings that might help 'bringing life to buildings', as seen in these buildings. © 2014 Elsevier Ltd. All rights reserved.


Gregorieff A.,Sinai University
Cell Research | Year: 2016

Wnt morphogens are notoriously elusive proteins. Thanks to a recent study published in Nature, Clevers and colleagues give us a first glimpse of a mammalian Wnt in action in the gut epithelium. © 2016 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences


Many agents, both pharmacologic and nonpharmacologic, have been studied to alleviate neonatal pain, and the research is extensive. The 2 most commonly studied nonpharmacologic agents studied have been sucrose and nonnutritive sucking (NNS). There is increasing evidence that the synergistic effect of sucrose and NNS is more effective than the effect of sucrose or NNS alone. The purpose of this integrative review of the literature was to determine whether there is a relationship between the synergistic effect of combining sucrose and NNS administered before and during painful procedures, and reducing procedural pain in both preterm and term neonates. This integrative review indicates that the combination of sucrose and NNS is a safe, effective, and clinically significant means of providing procedural pain relief in neonates, both term and preterm. Copyright © 2013 by The National Association of Neonatal Nurses.


Logan A.G.,Sinai University
Expert Review of Cardiovascular Therapy | Year: 2011

Hypertension, especially isolated systolic hypertension, is commonly found in older (60-79 years of age) and elderly (≥80 years of age) people. Antihypertensive drug therapy should be considered in all aging hypertensive patients, as treatment greatly reduces cardiovascular events. Most classes of antihypertensive medications may be used as first-line treatment with the possible exception of α- and -blockers. An initial blood pressure treatment goal is less than 140/90 mmHg in all older patients and less than 150/80 mmHg in the nonfrail elderly. The current paradigm of delaying therapeutic interventions until people are at moderate or high cardiovascular risk, a universal feature of hypertensive patients over 60 years of age, leads to vascular injury or disease that is only partially reversible with treatment. Future management will likely focus on intervening earlier to prevent accelerated vascular aging and irreversible arterial damage. © 2011 Expert Reviews Ltd.


Panier S.,Sinai University | Panier S.,Cancer Research UK Research Institute | Durocher D.,Sinai University | Durocher D.,University of Toronto
Nature Reviews Molecular Cell Biology | Year: 2013

Single DNA lesions such as DNA double-strand breaks (DSBs) can cause cell death or trigger genome rearrangements that have oncogenic potential, and so the pathways that mend and signal DNA damage must be highly sensitive but, at the same time, selective and reversible. When initiated, boundaries must be set to restrict the DSB response to the site of the lesion. The integration of positive and, crucially, negative control points involving post-translational modifications such as phosphorylation, ubiquitylation and acetylation is key for building fast, effective responses to DNA damage and for mitigating the impact of DNA lesions on genome integrity. © 2013 Macmillan Publishers Limited. All rights reserved.


Drexler M.,Sinai University
The bone & joint journal | Year: 2013

Total knee replacement (TKR) is one of the most common operations in orthopaedic surgery worldwide. Despite its scientific reputation as mainly successful, only 81% to 89% of patients are satisfied with the final result. Our understanding of this discordance between patient and surgeon satisfaction is limited. In our experience, focus on five major factors can improve patient satisfaction rates: correct patient selection, setting of appropriate expectations, avoiding preventable complications, knowledge of the finer points of the operation, and the use of both pre- and post-operative pathways. Awareness of the existence, as well as the identification of predictors of patient-surgeon discordance should potentially help with enhancing patient outcomes.


Vieth R.,University of Toronto | Vieth R.,Sinai University
Best Practice and Research: Clinical Endocrinology and Metabolism | Year: 2011

The Institutes of Medicine (IOM) recently revised the recommended dietary allowances (RDA) for vitamin D, to maintain serum 25-hydroxyvitamin D (25(OH)D) at or above 50 nmol/L, to sustain bone density, calcium absorption, and to minimize risk of osteomalacia and rickets. However there are compelling reasons why 25(OH)D should preferably exceed 75 nmol/L: (A) Scrutiny of actual data specified by the IOM relating 25(OH)D to bone density and osteomalacia shows the desirable minimum 25(OH)D to be 75 nmol/L (30 ng/mL). (B) Humans are primates, optimized through evolution to inhabit tropical latitudes, with serum 25(OH)D over 100 nmol/L. (C) Epidemiologic relationships show health benefits if 25(OH)D levels exceed 70 nmol/L; these include fewer falls, better tooth attachment, less colorectal cancer, improved depression and wellbeing. Some studies of populations at high-latitude relate higher 25(OH)D to risk of prostate cancer, pancreatic cancer or mortality. Those relationships are attributable to the dynamic fluctuations in 25(OH)D specific to high latitudes, and which can be corrected by maintaining 25(OH)D at steady, high levels throughout the year, the way they are in the tropics. (D) There are now many clinical trials that show benefits and/or no adversity with doses of vitamin D that raise serum 25(OH)D to levels beyond 75 nmol/L. Together, the evidence makes it very unlikely that further research will change the conclusion that risk of disease with serum 25(OH)D higher than 75 nmol/L is lower than the risk of disease if the serum 25(OH)D is approximately 53 nmol/L. © 2010 Elsevier Masson SAS. All rights reserved.

Loading Sinai University collaborators
Loading Sinai University collaborators